---
title: ICD Codes, Novel Rosacea Treatment & More | Your September LiVDerm Newsletter
---

As part of the LiVDerm mission to advance higher standards of dermatology care...

| View in browser SEPTEMBER       Industry Updates Healio Dermatology New study suggests ICD codes poorly correlate with skin cancer incidence in individual patients   Practice Update Recent Literature Review Examines Available Evidence on Oral Nail Growth Supplements   Dermatology Times Preventing Keloid Recurrence With SRT MD Edge Oral abrocitinib plus topical therapy safe, effective for teens with moderate to severe atopic dermatitis   Healio Psoriatic Disease Network meta-analysis suggests Risankizumab shows best benefit-risk profile for psoriasis treatment over long term   Dermatology Times Novel rosacea treatment demonstrates efficacy       Resource of the Month Gain valuable insights, and in-depth insider knowledge from leading figures in dermatology at your own pace. Access Webinar Spotlight       Faculty In the News LiVDerm Advisory Board Member, Dr. Johnathan Silverberg, MD recently led a post hoc analysis of 5 randomized clinical trials on pain and discomfort in patients with atopic dermatitis.    Read more LiVDerm Advisory Board Member, Dr. Linda Stein Gold, recently led a study on the impact of Apremilast on the severity and quality of life in mild to moderate psoriasis.   Read more       Best Blog Despite similarities in presentation, melasma can exhibit differences in clinical, etiological, and treatment aspects in male patients that require further study. Greater knowledge of the unique characteristics of melasma presentation in male patients can allow for the improvement of management strategies in this group. READ MORE       LiVDerm, 1801 N Military Trl Ste 200, Boca Raton, FL 33431-1810, United States, 561-893-8625 Unsubscribe Manage preferences |
| --- |